Compare ABX & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABX | BLFS |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | United States |
| Employees | 326 | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 805.2M | 923.5M |
| IPO Year | N/A | 2013 |
| Metric | ABX | BLFS |
|---|---|---|
| Price | $8.94 | $21.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.50 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 460.2K | 326.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $19.18 | $19.73 |
| Revenue Next Year | $14.60 | $17.82 |
| P/E Ratio | $74.88 | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $7.18 | $17.86 |
| 52 Week High | $10.54 | $29.57 |
| Indicator | ABX | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 56.20 |
| Support Level | $7.25 | $21.35 |
| Resistance Level | $9.74 | $26.14 |
| Average True Range (ATR) | 0.39 | 1.03 |
| MACD | -0.02 | 0.10 |
| Stochastic Oscillator | 55.45 | 68.35 |
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The company operates through four distinct yet complementary divisions: Abacus Life Solutions, Abacus Asset Group, Abacus Intel, and Abacus Wealth Advisors. It operates through three reportable segments, Asset management, Life solutions, and Technology services. It derives the majority revenue from Life solutions segment that generates revenues by buying, selling, and trading policies, and maintaining policies until receipt of death benefits. It also generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.